Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS)
Crossref DOI link: https://doi.org/10.1186/s12883-017-0845-y
Published Online: 2017-03-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Delgado, D.
Canham, L.
Cotterill, N.
Cottrell, D.
Drake, M. J.
Inglis, K.
Owen, D.
White, P.
Funding for this research was provided by:
Multiple Sclerosis Society (959/11)
